Xeomin

LOE Approaching

incobotulinumtoxina

BLAINJECTIONINJECTABLE
Approved
Jul 2010
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2

Mechanism of Action

Acetylcholine Release Inhibitors

Pharmacologic Class:

Acetylcholine Release Inhibitor

Clinical Trials (2)

NCT05340439Phase 2Unknown

INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT)

Started Jun 2022
30 enrolled
Spastic Cerebral Palsy
NCT04970407Phase 1Completed

A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants

Started Jul 2021
45 enrolled
Healthy Participants